Scholar All articles - Recent articles | Results 1 - 10 of about 61,600 for link between obesity and coronary heart disease. (0.17 seconds) |
… of coronary heart disease is associated with a higher incidence of nonalcoholic fatty liver disease …
L Zhang, K Pu, Z Chai, JB Dixon - Obesity Research & Clinical Practice, 2007 - Elsevier
... and family history of coronary artery disease, and hypertension ... into the blood;
(3) obesity and its ... circumference suggesting the genetic link between the two ...
Related Articles - Web Search
… : Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk - all 5 versions »
MC Carr, JD Brunzell - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
... guidelines may underestimate their coronary artery disease (CAD) risk. ... rises with
increasing obesity and sedentary ... Link between abdominal obesity and metabolic ...
Cited by 113 - Related Articles - Web Search - BL Direct
Adipokines: molecular links between obesity and atheroslcerosis - all 5 versions »
DCW Lau, B Dhillon, H Yan, PE Szmitko, S Verma - … Journal of Physiology- Heart and Circulatory Physiology, 2005 - Am Physiological Soc
... Subjects with coronary heart disease have lower adiponectin levels compared with
age ... ADIPOKINES ARE THE MOLECULAR LINK BETWEEN OBESITY AND METABOLIC SYNDROME. ...
Cited by 110 - Related Articles - Web Search - BL Direct
… A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation - all 5 versions »
P Dandona, A Aljada, A Chaudhuri, P Mohanty, R … - Circulation, 2005 - Am Heart Assoc
... to the incidence of coronary heart disease: results from ... A, Bandyopadhyay A.
Inflammation: the link between insulin resistance, obesity and diabetes. ...
Cited by 193 - Related Articles - Web Search
Insulin Resistance and Coronary Heart Disease - all 3 versions »
M LAAKSO, J KUUSISTO - The Metabolic Syndrome AT The Beginning of The Xxist Century …, 2005 - books.google.com
... 3. Laakso M. Insulin resistance and coronary heart disease. ... Chetrit A, Fuchs F.
Hyperinsulinemia: A link between hypertension, obesity and glucose ...
Cited by 98 - Related Articles - Web Search - BL Direct
Independent effect and population impact of obesity on fatal coronary heart disease in adults - all 3 versions »
DM Mann, J Lee, Y Liao, S Natarajan - Preventive Medicine, 2006 - Elsevier
... understanding of the relationships between obesity, diabetes, and ... SummaryPlus | Full
Text + Links | PDF (72 K ... WB Kannel, Overweight and obesity as determinants ...
Cited by 1 - Related Articles - Web Search
… Left Ventricular Remodeling and Diastolic Dysfunction in Patients Without Coronary Artery Disease - all 3 versions »
BD Powell, MM Redfield, KA Bybee, WK Freeman, CS … - The American Journal of Cardiology, 2006 - Elsevier
... designed to identify any associations between LV function ... Abstract | Full Text +
Links | PDF (482 K) | View ... Role of hypertension, diabetes, obesity, and race ...
Cited by 18 - Related Articles - Web Search
… of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy … - all 4 versions »
W Koenig, N Khuseyinova, J Baumert, C Meisinger, H … - Journal of the American College of Cardiology, 2006 - Elsevier
... been associated with future coronary heart disease (CHD) events ... cholesterol
(HDL-C), obesity, hypertension, and ... may represent a link between insulin resistance ...
Cited by 17 - Related Articles - Web Search - BL Direct
… Between Serum Resistin Levels and Insulin Resistance, Inflammation, and Coronary Artery Disease - all 4 versions »
R Ohmori, Y Momiyama, R Kato, H Taniguchi, M Ogura … - Journal of the American College of Cardiology, 2005 - Am Coll Cardio Found
... is an adipocytokine that may link obesity with insulin ... the role of resistin in obesity
and insulin ... However, association between resistin and coronary artery ...
Cited by 25 - Related Articles - Web Search - BL Direct
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers - all 3 versions »
D Rothenbacher, H Brenner, W Marz, W Koenig - European Heart Journal, 2005 - Eur Soc Cardiology
... who showed at least one coronary stenosis of ... fold risk for ischaemic heart disease
associated with ... It may therefore represent the link between obesity (or even ...
Cited by 45 - Related Articles - Web Search
Key authors: W Koenig - P Poirier - B Solymoss - D Rothenbacher - W Marz
|
| |||||||||||||||||||||||||||||||
| J Am Coll Cardiol, 2002; 40:937-943 © 2002 by the American College of Cardiology Foundation |
CLINICAL STUDY: OBESITY, DIABETES, AND HEART DISEASE
Relationship between obesity, insulin resistance, and coronary heart disease risk
* Department of Medicine, Stanford, California, USA Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA
Manuscript received August 27, 2001; revised manuscript received March 19, 2002, accepted June 4, 2002.
* Reprint requests and correspondence: Dr. Gerald M. Reaven, Falk CVRC Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305-5406, USA
greaven@cvmed.Stanford.edu
OBJECTIVES: The study goals were to: 1) define the relationship between body mass index (BMI) and insulin resistance in 314 nondiabetic, normotensive, healthy volunteers; and 2) determine the relationship between each of these two variables and coronary heart disease (CHD) risk factors.
BACKGROUND: The importance of obesity as a risk factor for type 2 diabetes and hypertension is well-recognized, but its role as a CHD risk factor in nondiabetic, normotensive individuals is less well established.
METHODS: Insulin resistance was quantified by determining the steady-state plasma glucose (SSPG) concentration during the last 30 min of a 180-min infusion of octreotide, glucose, and insulin. In addition, nine CHD risk factors: age, systolic blood pressure, diastolic blood pressure (DBP), total cholesterol, triglycerides (TG), high-density lipoprotein (HDL) cholesterol and low-density lipoprotein cholesterol concentrations, and glucose and insulin responses to a 75-g oral glucose load were measured in the volunteers.
RESULTS: The BMI and the SSPG concentration were significantly related (r = 0.465, p <> associated with each of the nine risk factors. In multiple regression analysis, SSPG concentration added modest to substantial power to BMI with regard to the prediction of DBP, HDL cholesterol and TG concentrations, and the glucose and insulin responses.
CONCLUSIONS: Obesity and insulin resistance are both powerful predictors of CHD risk, and insulin resistance at any given degree of obesity accentuates the risk of CHD and type 2 diabetes.
|
This article has been cited by other articles:
| J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1039 - 1049. [Abstract] [Full Text] [PDF] | ||||
| M. Langeveld, K. J. M. Ghauharali, H. P. Sauerwein, M. T. Ackermans, J. E. M. Groener, C. E. M. Hollak, J. M. Aerts, and M. J. Serlie Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin Resistance J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 845 - 851. [Abstract] [Full Text] [PDF] | ||||
| J.-P. Despres, P. Poirier, J. Bergeron, A. Tremblay, I. Lemieux, and N. Almeras From individual risk factors and the metabolic syndrome to global cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B24 - B33. [Abstract] [Full Text] [PDF] | ||||
| A. Kotronen and H. Yki-Jarvinen Fatty Liver: A Novel Component of the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 27 - 38. [Abstract] [Full Text] [PDF] | ||||
| U. Riserus, J. Arnlov, and L. Berglund Long-Term Predictors of Insulin Resistance: Role of lifestyle and metabolic factors in middle-aged men Diabetes Care, November 1, 2007; 30(11): 2928 - 2933. [Abstract] [Full Text] [PDF] | ||||
| K.-C. Sung, S. H. Kim, and G. M. Reaven Relationship Among Alcohol, Body Weight, and Cardiovascular Risk Factors in 27,030 Korean Men Diabetes Care, October 1, 2007; 30(10): 2690 - 2694. [Abstract] [Full Text] [PDF] | ||||
| S. H. Park, B. I. Kim, S. H. Kim, H. J. Kim, D. I. Park, Y. K. Cho, I. K. Sung, C. I. Sohn, H. Kim, D. K. Keum, et al. Body Fat Distribution and Insulin Resistance: Beyond Obesity in Nonalcoholic Fatty Liver Disease among Overweight Men J. Am. Coll. Nutr., August 1, 2007; 26(4): 321 - 326. [Abstract] [Full Text] [PDF] | ||||
| K. C. Sung, M. C. Ryan, B. S. Kim, Y. K. Cho, B. I. Kim, and G. M. Reaven Relationships Between Estimates of Adiposity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease in a Large Group of Nondiabetic Korean Adults Diabetes Care, August 1, 2007; 30(8): 2113 - 2118. [Abstract] [Full Text] [PDF] | ||||
| G. M. Reaven The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre? J. Am. Coll. Nutr., June 1, 2007; 26(3): 191 - 195. [Full Text] [PDF] | ||||
| T. McLaughlin, F. Abbasi, C. Lamendola, and G. Reaven Heterogeneity in the Prevalence of Risk Factors for Cardiovascular Disease and Type 2 Diabetes Mellitus in Obese Individuals: Effect of Differences in Insulin Sensitivity Arch Intern Med, April 9, 2007; 167(7): 642 - 648. [Abstract] [Full Text] [PDF] | ||||
| R. S. Beaser and P. Levy A Work in Progress, but a Useful Construct Circulation, April 3, 2007; 115(13): 1812 - 1818. [Full Text] [PDF] | ||||
| E. P. Weiss and J. O. Holloszy Improvements in Body Composition, Glucose Tolerance, and Insulin Action Induced by Increasing Energy Expenditure or Decreasing Energy Intake J. Nutr., April 1, 2007; 137(4): 1087 - 1090. [Abstract] [Full Text] [PDF] | ||||
| E. P Weiss, S. B Racette, D. T Villareal, L. Fontana, K. Steger-May, K. B Schechtman, S. Klein, J. O Holloszy, and and the Washington University School of Medicine C Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1033 - 1042. [Abstract] [Full Text] [PDF] | ||||
| C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF] | ||||
| A. R. Sinaiko, J. Steinberger, A. Moran, C.-P. Hong, R. J. Prineas, and D. R. Jacobs Jr Influence of Insulin Resistance and Body Mass Index at Age 13 on Systolic Blood Pressure, Triglycerides, and High-Density Lipoprotein Cholesterol at Age 19 Hypertension, October 1, 2006; 48(4): 730 - 736. [Abstract] [Full Text] [PDF] | ||||
| J. B. Meigs, P. W. F. Wilson, C. S. Fox, R. S. Vasan, D. M. Nathan, L. M. Sullivan, and R. B. D'Agostino Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2906 - 2912. [Abstract] [Full Text] [PDF] | ||||
| K. D. Ahuja, I. K Robertson, D. P Geraghty, and M. J Ball Effects of chili consumption on postprandial glucose, insulin, and energy metabolism Am. J. Clinical Nutrition, July 1, 2006; 84(1): 63 - 69. [Abstract] [Full Text] [PDF] | ||||
| M. von Eynatten, A. Hamann, D. Twardella, P. P. Nawroth, H. Brenner, and D. Rothenbacher Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart Disease Clin. Chem., May 1, 2006; 52(5): 853 - 859. [Abstract] [Full Text] [PDF] | ||||
| L. E. Bernstein, J. Berry, S. Kim, B. Canavan, and S. K. Grinspoon Effects of Etanercept in Patients With the Metabolic Syndrome. Arch Intern Med, April 24, 2006; 166(8): 902 - 908. [Abstract] [Full Text] [PDF] | ||||
| H. M. Farin, F. Abbasi, and G. M Reaven Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults Am. J. Clinical Nutrition, January 1, 2006; 83(1): 47 - 51. [Abstract] [Full Text] [PDF] | ||||
| P.H. Whincup, J.A. Gilg, A.E. Donald, M. Katterhorn, C. Oliver, D.G. Cook, and J.E. Deanfield Arterial Distensibility in Adolescents: The Influence of Adiposity, the Metabolic Syndrome, and Classic Risk Factors Circulation, September 20, 2005; 112(12): 1789 - 1797. [Abstract] [Full Text] [PDF] | ||||
| A. J. Caban, D. J. Lee, L. E. Fleming, O. Gomez-Marin, W. LeBlanc, and T. Pitman Obesity in US Workers: The National Health Interview Survey, 1986 to 2002 Am J Public Health, September 1, 2005; 95(9): 1614 - 1622. [Abstract] [Full Text] [PDF] | ||||
| J. M. Dekker, C. Girman, T. Rhodes, G. Nijpels, C. D.A. Stehouwer, L. M. Bouter, and R. J. Heine Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study Circulation, August 2, 2005; 112(5): 666 - 673. [Abstract] [Full Text] [PDF] | ||||
| V. Hirschler, C. Aranda, M. d. L. Calcagno, G. Maccalini, and M. Jadzinsky Can Waist Circumference Identify Children With the Metabolic Syndrome? Arch Pediatr Adolesc Med, August 1, 2005; 159(8): 740 - 744. [Abstract] [Full Text] [PDF] | ||||
| G. Reaven Counterpoint: Just Being Alive Is Not Good Enough Clin. Chem., August 1, 2005; 51(8): 1354 - 1357. [Full Text] [PDF] | ||||
| C. A. Geluk, F. W. Asselbergs, H. L. Hillege, S. J.L. Bakker, P. E. de Jong, F. Zijlstra, and W. H. van Gilst Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial Eur. Heart J., July 1, 2005; 26(13): 1314 - 1320. [Abstract] [Full Text] [PDF] | ||||
| Z. T. Bloomgarden Second World Congress on the Insulin Resistance Syndrome: Insulin resistance syndrome and nonalcoholic fatty liver disease Diabetes Care, June 1, 2005; 28(6): 1518 - 1523. [Full Text] [PDF] | ||||
| G. M. Reaven Dr. Reaven responds: Clin. Chem., June 1, 2005; 51(6): 1083 - 1084. [Full Text] [PDF] | ||||
| E. M. Allister, N. M. Borradaile, J. Y. Edwards, and M. W. Huff Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes Diabetes, June 1, 2005; 54(6): 1676 - 1683. [Abstract] [Full Text] [PDF] | ||||
| G. M. Reaven The Metabolic Syndrome: Requiescat in Pace Clin. Chem., June 1, 2005; 51(6): 931 - 938. [Abstract] [Full Text] [PDF] | ||||
| J. P. Curtis, J. G. Selter, Y. Wang, S. S. Rathore, I. S. Jovin, F. Jadbabaie, M. Kosiborod, E. L. Portnay, S. I. Sokol, F. Bader, et al. The Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure Arch Intern Med, January 10, 2005; 165(1): 55 - 61. [Abstract] [Full Text] [PDF] | ||||
| J. M.R. Gill, A. Al-Mamari, W. R. Ferrell, S. J. Cleland, C. J. Packard, N. Sattar, J. R. Petrie, and M. J. Caslake Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2375 - 2382. [Abstract] [Full Text] [PDF] | ||||
| J. McCord, B. J. Mundy, M. P. Hudson, A. S. Maisel, J. E. Hollander, W. T. Abraham, P. G. Steg, T. Omland, C. W. Knudsen, K. R. Sandberg, et al. Relationship Between Obesity and B-Type Natriuretic Peptide Levels Arch Intern Med, November 8, 2004; 164(20): 2247 - 2252. [Abstract] [Full Text] [PDF] | ||||
| H. S. Lim, G. Y. H. Lip, and A. D. Blann Plasma von Willebrand Factor and the Development of the Metabolic Syndrome in Patients with Hypertension J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5377 - 5381. [Abstract] [Full Text] [PDF] | ||||
| G. F. Lewis, S. Murdoch, K. Uffelman, M. Naples, L. Szeto, A. Albers, K. Adeli, and J. D. Brunzell Hepatic Lipase mRNA, Protein, and Plasma Enzyme Activity Is Increased in the Insulin-Resistant, Fructose-Fed Syrian Golden Hamster and Is Partially Normalized by the Insulin Sensitizer Rosiglitazone Diabetes, November 1, 2004; 53(11): 2893 - 2900. [Abstract] [Full Text] [PDF] | ||||
| S. H. Kim, F. Abbasi, and G. M. Reaven Impact of Degree of Obesity on Surrogate Estimates of Insulin Resistance Diabetes Care, August 1, 2004; 27(8): 1998 - 2002. [Abstract] [Full Text] [PDF] | ||||
| S. M Grundy Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am. J. Clinical Nutrition, July 1, 2004; 80(1): 1 - 2. [Full Text] [PDF] | ||||
| K P Morgan, A Kapur, and K J Beatt Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention Heart, July 1, 2004; 90(7): 732 - 738. [Abstract] [Full Text] [PDF] | ||||
| S. L.M. Coort, D. M. Hasselbaink, D. P.Y. Koonen, J. Willems, W. A. Coumans, A. Chabowski, G. J. van der Vusse, A. Bonen, J. F.C. Glatz, and J. J.F.P. Luiken Enhanced Sarcolemmal FAT/CD36 Content and Triacylglycerol Storage in Cardiac Myocytes From Obese Zucker Rats Diabetes, July 1, 2004; 53(7): 1655 - 1663. [Abstract] [Full Text] [PDF] | ||||
| R. Weiss, J. Dziura, T. S. Burgert, W. V. Tamborlane, S. E. Taksali, C. W. Yeckel, K. Allen, M. Lopes, M. Savoye, J. Morrison, et al. Obesity and the Metabolic Syndrome in Children and Adolescents N. Engl. J. Med., June 3, 2004; 350(23): 2362 - 2374. [Abstract] [Full Text] [PDF] | ||||
| K. L. Cheal, F. Abbasi, C. Lamendola, T. McLaughlin, G. M. Reaven, and E. S. Ford Relationship to Insulin Resistance of the Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic Syndrome Diabetes, May 1, 2004; 53(5): 1195 - 1200. [Abstract] [Full Text] [PDF] | ||||
| I. Lofgren, K. Herron, T. Zern, K. West, M. Patalay, N. S. Shachter, S. I. Koo, and M. L. Fernandez Waist Circumference Is a Better Predictor than Body Mass Index of Coronary Heart Disease Risk in Overweight Premenopausal Women J. Nutr., May 1, 2004; 134(5): 1071 - 1076. [Abstract] [Full Text] [PDF] | ||||
| T. McLaughlin, F. Abbasi, C. Lamendola, R. S. Frayo, and D. E. Cummings Plasma Ghrelin Concentrations Are Decreased in Insulin-Resistant Obese Adults Relative to Equally Obese Insulin-Sensitive Controls J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1630 - 1635. [Abstract] [Full Text] [PDF] | ||||
| S. M. Grundy, H. B. Brewer Jr, J. I. Cleeman, S. C. Smith Jr, C. Lenfant, and for the Conference Participants Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): e13 - 18. [Full Text] | ||||
| S. M. Grundy, H. B. Brewer Jr, J. I. Cleeman, S. C. Smith Jr, C. Lenfant, and for the Conference Participants Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition Circulation, January 27, 2004; 109(3): 433 - 438. [Full Text] [PDF] | ||||
| G. Reaven, F. Abbasi, and T. McLaughlin Obesity, Insulin Resistance, and Cardiovascular Disease Recent Prog. Horm. Res., January 1, 2004; 59(1): 207 - 223. [Abstract] [Full Text] | ||||
| T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, and G. Reaven Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant Ann Intern Med, November 18, 2003; 139(10): 802 - 809. [Abstract] [Full Text] [PDF] | ||||
| J. Rehman, R. V. Considine, J. E. Bovenkerk, J. Li, C. A. Slavens, R. M. Jones, and K. L. March Obesity is associated with increased levels of circulating hepatocyte growth factor J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1408 - 1413. [Abstract] [Full Text] [PDF] | ||||
HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
| |||||||||||||||||||||||||||||||
| J Am Coll Cardiol, 2002; 40:937-943 © 2002 by the American College of Cardiology Foundation |
|
CLINICAL STUDY: OBESITY, DIABETES, AND HEART DISEASE
Relationship between obesity, insulin resistance, and coronary heart disease risk
* Department of Medicine, Stanford, California, USA Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA
Manuscript received August 27, 2001; revised manuscript received March 19, 2002, accepted June 4, 2002.
* Reprint requests and correspondence: Dr. Gerald M. Reaven, Falk CVRC Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305-5406, USA
greaven@cvmed.Stanford.edu
OBJECTIVES: The study goals were to: 1) define the relationship between body mass index (BMI) and insulin resistance in 314 nondiabetic, normotensive, healthy volunteers; and 2) determine the relationship between each of these two variables and coronary heart disease (CHD) risk factors.
BACKGROUND: The importance of obesity as a risk factor for type 2 diabetes and hypertension is well-recognized, but its role as a CHD risk factor in nondiabetic, normotensive individuals is less well established.
METHODS: Insulin resistance was quantified by determining the steady-state plasma glucose (SSPG) concentration during the last 30 min of a 180-min infusion of octreotide, glucose, and insulin. In addition, nine CHD risk factors: age, systolic blood pressure, diastolic blood pressure (DBP), total cholesterol, triglycerides (TG), high-density lipoprotein (HDL) cholesterol and low-density lipoprotein cholesterol concentrations, and glucose and insulin responses to a 75-g oral glucose load were measured in the volunteers.
RESULTS: The BMI and the SSPG concentration were significantly related (r = 0.465, p <> associated with each of the nine risk factors. In multiple regression analysis, SSPG concentration added modest to substantial power to BMI with regard to the prediction of DBP, HDL cholesterol and TG concentrations, and the glucose and insulin responses.
CONCLUSIONS: Obesity and insulin resistance are both powerful predictors of CHD risk, and insulin resistance at any given degree of obesity accentuates the risk of CHD and type 2 diabetes.
|
This article has been cited by other articles:
| J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1039 - 1049. [Abstract] [Full Text] [PDF] | ||||
| M. Langeveld, K. J. M. Ghauharali, H. P. Sauerwein, M. T. Ackermans, J. E. M. Groener, C. E. M. Hollak, J. M. Aerts, and M. J. Serlie Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin Resistance J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 845 - 851. [Abstract] [Full Text] [PDF] | ||||
| J.-P. Despres, P. Poirier, J. Bergeron, A. Tremblay, I. Lemieux, and N. Almeras From individual risk factors and the metabolic syndrome to global cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B24 - B33. [Abstract] [Full Text] [PDF] | ||||
| A. Kotronen and H. Yki-Jarvinen Fatty Liver: A Novel Component of the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 27 - 38. [Abstract] [Full Text] [PDF] | ||||
| U. Riserus, J. Arnlov, and L. Berglund Long-Term Predictors of Insulin Resistance: Role of lifestyle and metabolic factors in middle-aged men Diabetes Care, November 1, 2007; 30(11): 2928 - 2933. [Abstract] [Full Text] [PDF] | ||||
| K.-C. Sung, S. H. Kim, and G. M. Reaven Relationship Among Alcohol, Body Weight, and Cardiovascular Risk Factors in 27,030 Korean Men Diabetes Care, October 1, 2007; 30(10): 2690 - 2694. [Abstract] [Full Text] [PDF] | ||||
| S. H. Park, B. I. Kim, S. H. Kim, H. J. Kim, D. I. Park, Y. K. Cho, I. K. Sung, C. I. Sohn, H. Kim, D. K. Keum, et al. Body Fat Distribution and Insulin Resistance: Beyond Obesity in Nonalcoholic Fatty Liver Disease among Overweight Men J. Am. Coll. Nutr., August 1, 2007; 26(4): 321 - 326. [Abstract] [Full Text] [PDF] | ||||
| K. C. Sung, M. C. Ryan, B. S. Kim, Y. K. Cho, B. I. Kim, and G. M. Reaven Relationships Between Estimates of Adiposity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease in a Large Group of Nondiabetic Korean Adults Diabetes Care, August 1, 2007; 30(8): 2113 - 2118. [Abstract] [Full Text] [PDF] | ||||
| G. M. Reaven The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre? J. Am. Coll. Nutr., June 1, 2007; 26(3): 191 - 195. [Full Text] [PDF] | ||||
| T. McLaughlin, F. Abbasi, C. Lamendola, and G. Reaven Heterogeneity in the Prevalence of Risk Factors for Cardiovascular Disease and Type 2 Diabetes Mellitus in Obese Individuals: Effect of Differences in Insulin Sensitivity Arch Intern Med, April 9, 2007; 167(7): 642 - 648. [Abstract] [Full Text] [PDF] | ||||
| R. S. Beaser and P. Levy A Work in Progress, but a Useful Construct Circulation, April 3, 2007; 115(13): 1812 - 1818. [Full Text] [PDF] | ||||
| E. P. Weiss and J. O. Holloszy Improvements in Body Composition, Glucose Tolerance, and Insulin Action Induced by Increasing Energy Expenditure or Decreasing Energy Intake J. Nutr., April 1, 2007; 137(4): 1087 - 1090. [Abstract] [Full Text] [PDF] | ||||
| E. P Weiss, S. B Racette, D. T Villareal, L. Fontana, K. Steger-May, K. B Schechtman, S. Klein, J. O Holloszy, and and the Washington University School of Medicine C Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1033 - 1042. [Abstract] [Full Text] [PDF] | ||||
| C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF] | ||||
| A. R. Sinaiko, J. Steinberger, A. Moran, C.-P. Hong, R. J. Prineas, and D. R. Jacobs Jr Influence of Insulin Resistance and Body Mass Index at Age 13 on Systolic Blood Pressure, Triglycerides, and High-Density Lipoprotein Cholesterol at Age 19 Hypertension, October 1, 2006; 48(4): 730 - 736. [Abstract] [Full Text] [PDF] | ||||
| J. B. Meigs, P. W. F. Wilson, C. S. Fox, R. S. Vasan, D. M. Nathan, L. M. Sullivan, and R. B. D'Agostino Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2906 - 2912. [Abstract] [Full Text] [PDF] | ||||
| K. D. Ahuja, I. K Robertson, D. P Geraghty, and M. J Ball Effects of chili consumption on postprandial glucose, insulin, and energy metabolism Am. J. Clinical Nutrition, July 1, 2006; 84(1): 63 - 69. [Abstract] [Full Text] [PDF] | ||||
| M. von Eynatten, A. Hamann, D. Twardella, P. P. Nawroth, H. Brenner, and D. Rothenbacher Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart Disease Clin. Chem., May 1, 2006; 52(5): 853 - 859. [Abstract] [Full Text] [PDF] | ||||
| L. E. Bernstein, J. Berry, S. Kim, B. Canavan, and S. K. Grinspoon Effects of Etanercept in Patients With the Metabolic Syndrome. Arch Intern Med, April 24, 2006; 166(8): 902 - 908. [Abstract] [Full Text] [PDF] | ||||
| H. M. Farin, F. Abbasi, and G. M Reaven Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults Am. J. Clinical Nutrition, January 1, 2006; 83(1): 47 - 51. [Abstract] [Full Text] [PDF] | ||||
| P.H. Whincup, J.A. Gilg, A.E. Donald, M. Katterhorn, C. Oliver, D.G. Cook, and J.E. Deanfield Arterial Distensibility in Adolescents: The Influence of Adiposity, the Metabolic Syndrome, and Classic Risk Factors Circulation, September 20, 2005; 112(12): 1789 - 1797. [Abstract] [Full Text] [PDF] | ||||
| A. J. Caban, D. J. Lee, L. E. Fleming, O. Gomez-Marin, W. LeBlanc, and T. Pitman Obesity in US Workers: The National Health Interview Survey, 1986 to 2002 Am J Public Health, September 1, 2005; 95(9): 1614 - 1622. [Abstract] [Full Text] [PDF] | ||||
| J. M. Dekker, C. Girman, T. Rhodes, G. Nijpels, C. D.A. Stehouwer, L. M. Bouter, and R. J. Heine Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study Circulation, August 2, 2005; 112(5): 666 - 673. [Abstract] [Full Text] [PDF] | ||||
| V. Hirschler, C. Aranda, M. d. L. Calcagno, G. Maccalini, and M. Jadzinsky Can Waist Circumference Identify Children With the Metabolic Syndrome? Arch Pediatr Adolesc Med, August 1, 2005; 159(8): 740 - 744. [Abstract] [Full Text] [PDF] | ||||
| G. Reaven Counterpoint: Just Being Alive Is Not Good Enough Clin. Chem., August 1, 2005; 51(8): 1354 - 1357. [Full Text] [PDF] | ||||
| C. A. Geluk, F. W. Asselbergs, H. L. Hillege, S. J.L. Bakker, P. E. de Jong, F. Zijlstra, and W. H. van Gilst Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial Eur. Heart J., July 1, 2005; 26(13): 1314 - 1320. [Abstract] [Full Text] [PDF] | ||||
| Z. T. Bloomgarden Second World Congress on the Insulin Resistance Syndrome: Insulin resistance syndrome and nonalcoholic fatty liver disease Diabetes Care, June 1, 2005; 28(6): 1518 - 1523. [Full Text] [PDF] | ||||
| G. M. Reaven Dr. Reaven responds: Clin. Chem., June 1, 2005; 51(6): 1083 - 1084. [Full Text] [PDF] | ||||
| E. M. Allister, N. M. Borradaile, J. Y. Edwards, and M. W. Huff Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes Diabetes, June 1, 2005; 54(6): 1676 - 1683. [Abstract] [Full Text] [PDF] | ||||
| G. M. Reaven The Metabolic Syndrome: Requiescat in Pace Clin. Chem., June 1, 2005; 51(6): 931 - 938. [Abstract] [Full Text] [PDF] | ||||
| J. P. Curtis, J. G. Selter, Y. Wang, S. S. Rathore, I. S. Jovin, F. Jadbabaie, M. Kosiborod, E. L. Portnay, S. I. Sokol, F. Bader, et al. The Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure Arch Intern Med, January 10, 2005; 165(1): 55 - 61. [Abstract] [Full Text] [PDF] | ||||
| J. M.R. Gill, A. Al-Mamari, W. R. Ferrell, S. J. Cleland, C. J. Packard, N. Sattar, J. R. Petrie, and M. J. Caslake Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2375 - 2382. [Abstract] [Full Text] [PDF] | ||||
| J. McCord, B. J. Mundy, M. P. Hudson, A. S. Maisel, J. E. Hollander, W. T. Abraham, P. G. Steg, T. Omland, C. W. Knudsen, K. R. Sandberg, et al. Relationship Between Obesity and B-Type Natriuretic Peptide Levels Arch Intern Med, November 8, 2004; 164(20): 2247 - 2252. [Abstract] [Full Text] [PDF] | ||||
| H. S. Lim, G. Y. H. Lip, and A. D. Blann Plasma von Willebrand Factor and the Development of the Metabolic Syndrome in Patients with Hypertension J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5377 - 5381. [Abstract] [Full Text] [PDF] | ||||
| G. F. Lewis, S. Murdoch, K. Uffelman, M. Naples, L. Szeto, A. Albers, K. Adeli, and J. D. Brunzell Hepatic Lipase mRNA, Protein, and Plasma Enzyme Activity Is Increased in the Insulin-Resistant, Fructose-Fed Syrian Golden Hamster and Is Partially Normalized by the Insulin Sensitizer Rosiglitazone Diabetes, November 1, 2004; 53(11): 2893 - 2900. [Abstract] [Full Text] [PDF] | ||||
| S. H. Kim, F. Abbasi, and G. M. Reaven Impact of Degree of Obesity on Surrogate Estimates of Insulin Resistance Diabetes Care, August 1, 2004; 27(8): 1998 - 2002. [Abstract] [Full Text] [PDF] | ||||
| S. M Grundy Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am. J. Clinical Nutrition, July 1, 2004; 80(1): 1 - 2. [Full Text] [PDF] | ||||
| K P Morgan, A Kapur, and K J Beatt Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention Heart, July 1, 2004; 90(7): 732 - 738. [Abstract] [Full Text] [PDF] | ||||
| S. L.M. Coort, D. M. Hasselbaink, D. P.Y. Koonen, J. Willems, W. A. Coumans, A. Chabowski, G. J. van der Vusse, A. Bonen, J. F.C. Glatz, and J. J.F.P. Luiken Enhanced Sarcolemmal FAT/CD36 Content and Triacylglycerol Storage in Cardiac Myocytes From Obese Zucker Rats Diabetes, July 1, 2004; 53(7): 1655 - 1663. [Abstract] [Full Text] [PDF] | ||||
| R. Weiss, J. Dziura, T. S. Burgert, W. V. Tamborlane, S. E. Taksali, C. W. Yeckel, K. Allen, M. Lopes, M. Savoye, J. Morrison, et al. Obesity and the Metabolic Syndrome in Children and Adolescents N. Engl. J. Med., June 3, 2004; 350(23): 2362 - 2374. [Abstract] [Full Text] [PDF] | ||||
| K. L. Cheal, F. Abbasi, C. Lamendola, T. McLaughlin, G. M. Reaven, and E. S. Ford Relationship to Insulin Resistance of the Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic Syndrome Diabetes, May 1, 2004; 53(5): 1195 - 1200. [Abstract] [Full Text] [PDF] | ||||
| I. Lofgren, K. Herron, T. Zern, K. West, M. Patalay, N. S. Shachter, S. I. Koo, and M. L. Fernandez Waist Circumference Is a Better Predictor than Body Mass Index of Coronary Heart Disease Risk in Overweight Premenopausal Women J. Nutr., May 1, 2004; 134(5): 1071 - 1076. [Abstract] [Full Text] [PDF] | ||||
| T. McLaughlin, F. Abbasi, C. Lamendola, R. S. Frayo, and D. E. Cummings Plasma Ghrelin Concentrations Are Decreased in Insulin-Resistant Obese Adults Relative to Equally Obese Insulin-Sensitive Controls J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1630 - 1635. [Abstract] [Full Text] [PDF] | ||||
| S. M. Grundy, H. B. Brewer Jr, J. I. Cleeman, S. C. Smith Jr, C. Lenfant, and for the Conference Participants Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): e13 - 18. [Full Text] | ||||
| S. M. Grundy, H. B. Brewer Jr, J. I. Cleeman, S. C. Smith Jr, C. Lenfant, and for the Conference Participants Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition Circulation, January 27, 2004; 109(3): 433 - 438. [Full Text] [PDF] | ||||
| G. Reaven, F. Abbasi, and T. McLaughlin Obesity, Insulin Resistance, and Cardiovascular Disease Recent Prog. Horm. Res., January 1, 2004; 59(1): 207 - 223. [Abstract] [Full Text] | ||||
| T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, and G. Reaven Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant Ann Intern Med, November 18, 2003; 139(10): 802 - 809. [Abstract] [Full Text] [PDF] | ||||
| J. Rehman, R. V. Considine, J. E. Bovenkerk, J. Li, C. A. Slavens, R. M. Jones, and K. L. March Obesity is associated with increased levels of circulating hepatocyte growth factor J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1408 - 1413. [Abstract] [Full Text] [PDF] | ||||
HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
Scholar | Results 1 - 6 of 6. (0.15 seconds) |
Waist circumference and body composition in relation to all-cause mortality in middle-aged men and …
J Bigaard, K Frederiksen, A Tjønneland, BL Thomsen … - International Journal of Obesity, 2005 - nature.com
Waist circumference is directly related to all-cause mortality when adjusted for
body mass index (BMI). Body fat and fat-free body mass, when mutually adjusted,
show with increasing values an increasing and decreasing relation to ...
Cited by 30 - Related Articles - Web Search - Check 1cate!
Waist circumference and body composition in relation to all-cause mortality in middle-aged men and …
J BIGAARD, K FREDERIKSEN, A TJØNNELAND, BL THOMSEN … - International journal of obesity, 2005 - cat.inist.fr
OBJECTIVE: Waist circumference is directly related to all-cause mortality when
adjusted for body mass index(BMI). Body fat and fat-free body mass, when
mutually adjusted, show with increasing values an increasing and decreasing ...
Web Search - Check 1cate!
Waist circumference and body composition in relation to all-cause mortality in middle-aged men and …
J Bigaard, K Frederiksen, Tj nneland, A., BL … - International Journal of Obesity, 2005 - cababstractsplus.org
OBJECTIVE: Waist circumference is directly related to all-cause mortality when
adjusted for body mass index (BMI). Body fat and fat-free body mass, when
mutually adjusted, show with increasing values an increasing and decreasing ...
Web Search - Check 1cate!
Waist circumference and body composition in relation to all-cause mortality in middle-aged men and …
J Bigaard, K Frederiksen, A Tjønneland, BL Thomsen … - Int J Obes Relat Metab Disord., 2005 - forskningsbasen.deff.dk
Research database > Search. Note: This is a beta version of the new Research
Database. To search for data from suppliers not available on this site,
please visit the current production. Any, Flere ...
Cached - Web Search - Check 1cate!
Waist circumference and body composition in relation to all-cause mortality in middle-aged men and …
J Bigaard, K Frederiksen, A Tjønneland, BL Thomsen … - Int J Obes Relat Metab Disord., 2005 - forskningsbasen.deff.dk
Research database > Search. Note: This is a beta version of the new Research
Database. To search for data from suppliers not available on this site,
please visit the current production. Any, Flere ...
Cached - Web Search - Check 1cate!
Waist circumference and body composition in relation to all-cause mortality in middle-aged men and …
J Bigaard, K Frederiksen, A Tjonneland, BL Thomsen … - Int J Obes (Lond), 2005 - ncbi.nlm.nih.gov
OBJECTIVE: Waist circumference is directly related to all-cause mortality when
adjusted for body mass index (BMI). Body fat and fat-free body mass, when
mutually adjusted, show with increasing values an increasing and decreasing ...
Web Search
- Check 1cate!
Scholar | Results 1 - 4 of 4. (0.09 seconds) |
Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria
NJ Wareham - BMJ, 2001 - pubmedcentral.nih.gov
The first group of issues considered by the National Screening Committee relates
to the condition for which screening is proposed. In the case of type 2
diabetes, these issues are relatively uncontroversial. The scale of ...
Cited by 59 - Related Articles - Web Search - BL Direct
Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria.
NJ Wareham, SJ Griffin - BMJ, 2001 - ncbi.nlm.nih.gov
BMJ. 2001 Apr 21;322(7292):986-8. Click here
to read Click here to read Comment in ...
Web Search
Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria
NJ Wareham, SJ Griffin - BMJ: British Medical Journal, 2001 - pubmedcentral.nih.gov
The first group of issues considered by the National Screening Committee relates
to the condition for which screening is proposed. In the case of type 2
diabetes, these issues are relatively uncontroversial. The scale of ...
Web Search
Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria
NJ WAREHAM, SJ GRIFFIN - BMJ. British medical journal(International ed.), 2001 - cat.inist.fr
Should we screen for type 2 diabetes? Evaluation against National Screening Committee
criteria. Nicholas J WAREHAM, Simon J GRIFFIN BMJ. British medical journal(
International ed.) 322:72927292, 986-988, British Medical Association, 2001. ...
Web Search
Scholar | Results 1 - 7 of 7. (0.20 seconds) |
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
AH Mokdad, ES Ford, BA Bowman, WH Dietz, F Vinicor … - JAMA, 2003 - Am Med Assoc
Context Obesity and diabetes are increasing in the United States. ... Objective
To estimate the prevalence of obesity and diabetes among US adults in 2001. ...
Design, Setting, and Participants Random-digit telephone survey of 195 005 ...
Cited by 1287 - Related Articles - Web Search - BL Direct
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
AH MOKDAD, ES FORD, BA BOWMAN, WH DIETZ, F VINICOR … - JAMA, the journal of the American Medical Association, 2003 - cat.inist.fr
Context Obesity and diabetes are increasing in the United States. Objective To
estimate the prevalence of obesity and diabetes among US adults in 2001. Design,
Setting, and Participants Random-digit telephone survey of 195 005 adults ...
Web Search
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.
AH Mokdad, ES Ford, BA Bowman, WH Dietz, F Vinicor … - JAMA, 2003 - ncbi.nlm.nih.gov
CONTEXT: Obesity and diabetes are increasing in the United States. OBJECTIVE: To
estimate the prevalence of obesity and diabetes among US adults in 2001. DESIGN,
SETTING, AND PARTICIPANTS: Random-digit telephone survey of 195 005 adults ...
Web Search
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
AH Mokdad, ES Ford, BA Bowman, WH Dietz, F Vinicor … - JAMA, 2003 - rushakoff.com
O BESITY AND DIABETES ARE major causes of morbid- ity and mortality in the
United States. 1-3 Evidence from several studies indicates that obe- sity and
weight gain are associated with an increased risk of diabetes 4,5 and that ...
Web Search
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
AH Mokdad, ES Ford, BA Bowman, WH Dietz, F Vinicor … - JAMA, 2003 - rushakoff.com
O BESITY AND DIABETES ARE major causes of morbid- ity and mortality in the
United States. 1-3 Evidence from several studies indicates that obe- sity and
weight gain are associated with an increased risk of diabetes 4,5 and that ...
Web Search
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
AH Mokdad, ES Ford, BA Bowman, WH Dietz, F Vinicor … - JAMA: The Journal of the American Medical Association, 2003 - jama.waldenu.edu
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Obesity and ...
Cached - Web Search
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
AH Mokdad, ES Ford, BA Bowman, WH Dietz, F Vinicor … - JAMA, 2003 - keepitoff.com
O BESITY AND DIABETES ARE major causes of morbid- ity and mortality in the
United States. 1-3 Evidence from several studies indicates that obe- sity and
weight gain are associated with an increased risk of diabetes 4,5 and that ...
Web Search
Scholar | Results 1 - 3 of 3. (0.09 seconds) |
[BOOK] Evaluation in Health Promotion: Principles and Perspectives
I Rootman - 2001 - books.google.com
The World Health Organization was established in 1948 as a specialized agency
ofthe United Nations serving as the directing and coordinating author- ity for
international health matters and public health. One ofWHO's constitu- ...
Cited by 66 - Related Articles - Web Search
Evaluation in health promotion: principles and perspectives
I Rootman - Copenhagen;, 2001, 27 p.(WHO Regional Publications. European …, 2001 - bvsde.paho.org
Base de datos : BVSDE.BIBLIOGRAFICA. Búsqueda : BVSDE.REP2000.00031708 [Identificador
único]. Referencias encontradas : 1. Mostrando: 1 .. 1 en el formato [Largo]. pagina
1 de 1, 1 / 1, bvsde.bibliografica, seleccionar. imprimir. ...
Cached - Web Search
Evaluation in health promotion: principles and perspectives.
I Rootman - Copenhagen, 2001 - bases.bireme.br
Base de dados : REPIDISCA. Pesquisa : 161480 [Identificador único]. Referências
encontradas : 1 [refinar]. Mostrando: 1 .. 1 no formato [Detalhado]. página 1 de
1, 1 / 1, REPIDISCA, seleciona. para imprimir. Texto Completo. Id: 161480. ...
Cached - Web Search
No comments:
Post a Comment